Medications for Adolescents and Young Adults With Autism Spectrum Disorders: A Systematic Review | Zendy

Dwayne Dove | Zendy; Zachary Warren | Zendy; Melissa L McPheeters | Zendy; Julie Lounds Taylor | Zendy; Nila A Sathe | Zendy; Jeremy VeenstraVanderWeele | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Medications for Adolescents and Young Adults With Autism Spectrum Disorders: A Systematic Review

Author(s) -

Dwayne Dove,

Zachary Warren,

Melissa L McPheeters,

Julie Lounds Taylor,

Nila A Sathe,

Jeremy VeenstraVanderWeele

Publication year - 2012

Publication title -

pediatrics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.611

H-Index - 345

eISSN - 1098-4275

pISSN - 0031-4005

DOI - 10.1542/peds.2012-0683

Subject(s) - medicine , risperidone , psycinfo , autism , autism spectrum disorder , medline , population , psychological intervention , psychiatry , systematic review , intervention (counseling) , clinical psychology , antipsychotic , pediatrics , schizophrenia (object oriented programming) , environmental health , political science , law

Although many treatments have been studied in children with autism spectrum disorders (ASDs), less attention has focused on interventions that may be helpful in adolescents and young adults with ASD. The goal of this study was to systematically review evidence regarding medication treatments for individuals between the ages of 13 and 30 years with ASD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research